baber/WOPTO huggingface dataset:
Patent CA-3192616-A1 (CA)
Title: Method and system for secure distribution of symmetric encryption keys using quantum key distribution (qkd)
Inventor: D'SOUZA IAN
IPC: H04L9/08
Filed: 2023-03-10
Abstract: Various embodiments described herein generally relate to a method and system for secure distribution of symmetric encryption keys using quantum key distribution (QKD). In at least one embodiment, there is provided a method for secure communication, comprising: establishing one or more secure keys at a first and second ground station using a quantum key distribution (QKD) protocol; transmitting from the first station to the second station a plurality of encryption keys, wherein the transmitting comprises: encrypting, at the first station, the plurality of encryption keys using at least one of the one or more of secure keys to generate an encrypted batch of keys; transmitting the encrypted batch of keys to the second station; and decrypting, at the second station, the encrypted batch of keys using the at least one secure key to access the plurality of encryption keys.
Patent CA-3193244-A1 (CA)
Inventor: LYNN GEOFFREY MARTIN
IPC: A61K9/51
Filed: 2021-09-21
Abstract: La divulgation concerne un copolymère séquencé amphiphile ayant l'une quelconque des formules D-S-H, S(D)-H, S-H(D), D-S-H-S, D-S-H-S-D, S(D)-H-S, S(D)-H-S(D) ou S-H(D)-S S est un bloc hydrophile; H est un bloc hydrophobe; D est une molécule de médicament; ( ) indique que le groupe est lié directement ou indirectement en tant que chaîne latérale ou en tant que partie d'un groupe de chaînes latérales au groupe adjacent; et le trait d'union, « - » (ou parfois « ? »), indique que chacun des S, H ou D adjacents sont liés directement l'un à l'autre ou indirectement l'un à l'autre par l'intermédiaire d'un lieur, en outre, le bloc hydrophile comprend un premier monomère hydrophile et le bloc hydrophobe comprend un premier monomère hydrophobe et un second monomère hydrophobe.
Patent CA-3193576-A1 (CA)
Inventor: PARK KYUNGMIN
IPC: H04W76/27
Filed: 2021-09-23
Abstract: A base station central unit control plane (CU-CP) receives an indication of completion of a small data transmission (SDT) procedure of a wireless device. The base station CU-CP sends, to the wireless device, a radio resource control (RRC) release message based on the indication of the completion.
Patent CA-3193961-A1 (CA)
Title: Nucleases iscb reprogrammables et leurs utilisations
Inventor: ALTAE-TRAN HAN
IPC: A61K38/46
Filed: 2021-10-22
Abstract: L'invention concerne des systèmes, des méthodes et des compositions pour cibler des polynucléotides. En particulier, l'invention concerne des systèmes de ciblage d'ADN modifié comprenant des polypeptides IscB, de nouvelles nucléases IscB et des éléments d'acide nucléique de ciblage reprogrammables, ainsi que des méthodes et une application d'utilisation.
Patent CA-3194785-A1 (CA)
Title: Anhydrous alcohol-free silky fragrance formulation
Inventor: MEEHAN MATTHEW
IPC: A61K8/37
Filed: 2021-10-13
Abstract: An anhydrous alcohol -free fragrance carrier composition having a silky luxurious texture and feel, comprising at least one perfume compound, present in an amount of about 1 to 40 percent by weight relative to the total weight of the composition; triethyl citrate, present in an amount of about 10 to 50 percent by weight relative to the total weight of the composition; and ethyl hexyl glycerin in an amount of about 10 to 40 percent by weight relative to the total weight of the composition, or combination thereof. Moreover, the formula is preservative-free comprising natural bacteriostatic properties and further improves the aesthetics thereof. The product can be used with a variety of cosmetic or fragrance-based products.
Patent CA-3196318-A1 (CA)
Inventor: WIEDERHOLD HOLGER
IPC: C07C29/48
Filed: 2021-10-07
Abstract: The method for preparing 1,2-propanediol comprises the steps (a) reacting propene with hydrogen peroxide in the presence of a phase transfer catalyst and a heteropolytungstate in a liquid reaction mixture comprising an aqueous phase with a maximum apparent pH of 6 and an organic phase comprising a solvent having a solubility in water at 20 °C of less than 500 mg/kg; (b) separating the liquid reaction mixture of step a) into an aqueous phase comprising 1,2-propanediol and an organic phase; (c) recycling at least a part of the separated organic phase to step a); (d) extracting the separated aqueous phase with an extractant solution comprising the same phase transfer catalyst and solvent as used in step a) to provide an extracted aqueous phase and an extract phase; (e) recycling at least a part of the extract phase to step a); and (f) recovering 1,2-propanediol from the extracted aqueous phase.
Patent CA-3197431-A1 (CA)
Title: Apparatus for air measurements
Inventor: JAY OLIVER
IPC: G01W1/00
Filed: 2021-10-27
Abstract: An apparatus (200) for shielding a sensor, the sensor being configured to measure one or more meteorological parameters, the apparatus (200) including: a first shielding element (202) to be irradiated by sunlight, the first shielding element (202) having a hollow body (204) providing a longitudinal central axis (208), the body (204) at least partly surrounding a chamber (206) in which the sensor is to be located; a second shielding element (212) axially spaced from an upper portion of the body (204) to form an air opening between the first and second shielding elements (202, 212) to permit air to pass from the chamber (206) and across the body (204); the apparatus (200) further including an airflow generator (214) positioned within the chamber (206) and operatively associated with the first and second shielding elements (202, 212) to provide an airflow between the opening and the chamber (206).
Patent CA-3200737-A1 (CA)
Inventor: VAN EGMOND JAN W
IPC: C08F110/06
Filed: 2021-11-30
Abstract: L'invention concerne la production de polymères d'oléfine ayant une hauteur maitrisée de teneur en matière soluble dans le xylène. Par exemple, des polymères de polypropylène ayant une teneur en matière soluble dans le xylène relativement élevée peuvent être produits. Les polymères sont produits à l'aide de donneurs d'électrons externes particuliers. Les polymères peuvent être produits sans l'utilisation de donneur d'électrons externe contenant du silicium. Il a été découvert que le procédé produit des polymères ayant non seulement une teneur en matière soluble dans le xylène relativement élevée mais encore moins de fines et une distribution étroite de la taille des particules
Patent CA-3200827-A1 (CA)
Inventor: GU XUELAN
IPC: A61P17/10
Filed: 2021-12-06
Abstract: L'invention concerne une composition de soins personnels comprenant un extrait de moringa ; un extrait de plante du genre Theobroma ; et 0,00001 à 0,08 % d'un composé de vitamine B3 en poids de la composition.
Patent CA-3200877-A1 (CA)
Inventor: ANDER MATS
IPC: C07K14/31
Filed: 2021-11-10
Abstract: L'invention concerne un domaine de protéine A de liaison à Fc muté, stable en milieu alcalin, ayant au moins 95 % d'identité avec SEQ ID NO : 8 ou SEQ ID NO : 9.
Patent CA-3201205-A1 (CA)
Title: Oligonucleotides
Inventor: PHILPOTT MARTIN
IPC: C12Q1/6848
Filed: 2021-12-02
Abstract: L'invention concerne des procédés d'ajout de séquences d'identification à des polynucléotides d'un réseau. Les séquences d'identification comprennent une pluralité de séquences nucléotidiques. L'invention concerne également des réseaux de polynucléotides ayant des séquences d'identification, des microparticules comprenant lesdits réseaux, une pluralité desdites microparticules, des surfaces comprenant lesdits réseaux, des kits et des procédés pour générer des bibliothèques à l'aide du réseau, des procédés pour déterminer la précision de séquençage ou d'amplification d'un réseau, et des procédés d'analyse desdites bibliothèques.
Patent CA-3202925-A1 (CA)
Title: Ball-clamp type fall arrester for drill pipe
Inventor: LIU XUYONG
IPC: E21B19/10
Filed: 2023-06-12
Abstract: The present invention discloses a ball-clamp type fall arrester for a drill pipe, which includes a base and a steel ball seat arranged in the base. The steel ball seat is provided with a liftable steel ball frame. A side wall of the steel ball frame is provided with a plurality of limit hole. An inner wall of the steel ball seat is provided with a guide ramp. The plurality of limit holes are respectively provided with a plurality of steel balls which are movable radially. When the steel ball frame is lifted or lowered, a radial position of each steel ball in a corresponding limit hole is positioned by the guide ramp.
Patent CA-3203612-A1 (CA)
Title: Analogues de la conolidine servant de modulateurs selectifs d'ackr3 pour traiter le cancer
Inventor: CHEVIGNE ANDY
IPC: C07D471/18
Filed: 2021-12-22
Abstract: La présente invention concerne des composés représentés par, par exemple, les formules (2), (1A), (IB) ou (1C) en tant que modulateurs du récepteur 3 de chimiokine atypique sélective (ACKR3) pour le traitement, par exemple, du cancer, d'une maladie vasculaire athéroscléreuse, de maladies cardiovasculaires, de la fibrose (par exemple, une fibrose cardiaque), de maladies et d'affections inflammatoires ou auto-immunes, des états de vascularisation excessive ou anormale (par exemple, une cicatrisation de plaie), les troubles de la différenciation et de la mobilisation des cellules souches, des dysfonctionnements cérébraux et neuronaux (par exemple la maladie d'Alzheimer, la sclérose en plaques et les maladies démyélinisantes), un dysfonctionnement des reins, un dysfonctionnement rénal, une prééclampsie, une infection par le virus de l'immunodéficience humaine (VIH) et l'obésité. L'invention concerne en outre lesdits composés destinés à être utilisés dans des méthodes de diagnostic, de prédiction, de pronostic et/ou de surveillance in vitro ou ex vivo d'une maladie ou d'une affection caractérisée par un taux aberrant de polypeptide ACKR3, ainsi que pour une utilisation dans des méthodes in vitro pour identifier un agent utile comme agent thérapeutique. Un exemple de composé est par exemple WW-1 : (Formule)
Patent CA-3204643-A1 (CA)
Inventor: Gildas Martin
IPC: B64C1/14
Filed: 2022-01-14
Abstract: The invention relates to an assembly for providing stabilising guidance to a semi-plug aircraft door equipped with an opening/closing mechanism. The door frame (3) is provided with stops (7) at the front and at the rear on which the door with its stops (8) bears when it is closed. A door arm (4) links the door (2) to the door frame (3). A guiding connecting rod (6), referred to as a stabilising guiding connecting rod and located on a door edge (2h) extending parallel to the longitudinal axis of the vehicle, is mobile, being able to move in translation at one of its ends in relation to the door in the longitudinal direction of the aircraft during the phases of disengaging and re-engaging the stops (7, 8). During the swivelling and swivelling return phases, the stabilising rod (6) is locked to the door by a lever locking mechanism (9) capable of being actuated by a return means.
Patent CA-3205356-A1 (CA)
Title: Aircraft engine, gas turbine intake therefore, and method of guiding exhaust gasses
Inventor: LEFEBVRE GUY
IPC: B64D27/02
Filed: 2023-05-03
Abstract: The gas turbine intake can have a swirl housing having an inlet portion fluidly connecting an exhaust conduit, an annular outlet defined around a central axis and fluidly connecting a turbine gas path, a swirl path extending circumferentially around the central axis from the inlet portion to a circumferential outlet, the circumferential outlet fluidly connected back into the inlet portion, and vanes located in the swirl housing, the vanes circumferentially interspaced from one another relative the central axis and located radially inwardly from the swirl path relative the central axis, the swirl path being free of the vanes.
Patent CA-3205407-A1 (CA)
Title: Modified polypeptide having xylanase activity
Inventor: YANG TAE JOO
IPC: C12N9/24
Filed: 2021-12-15
Abstract: The present invention relates to: a variant polypeptide having xylanase activity; and a use thereof.
Patent CA-3205430-A1 (CA)
Title: Methods and processes for non-invasive assessment of genetic variations
Inventor: HANNUM GREGORY
IPC: G16B20/10
Filed: 2014-10-02
Abstract: Provided herein are methods for reducing bias in sequence reads for a sample, the methods comprising (a) generating a relationship between (i) local genome bias estimates and (ii) bias frequencies for sequence reads of a test sample, thereby generating a sample bias relationship, wherein, the sequence reads are of circulating cell-free nucleic acid from the test sample, and the sequence reads are mapped to a reference genome; (b) comparing the sample bias relationship and a reference bias relationship, thereby generating a comparison, wherein, the reference bias relationship is between (i) local genome bias estimates and (ii) the bias frequencies for a reference;  and (c) normalizing counts of the sequence reads for the sample according to the comparison determined in (b), whereby bias in the sequence reads for the sample is reduced.
Patent CA-3207762-A1 (CA)
Title: Dispositif d?aide au centrage pour boroscope
Inventor: PETERS JAN OKE
IPC: G01N21/954
Filed: 2022-02-17
Abstract: L'invention concerne un dispositif d?aide au centrage (1) pour boroscope, ainsi qu'un ensemble (10) comprenant un tel dispositif d?aide au centrage (2) et un boroscope (11). Le dispositif d?aide au centrage (1) comprend un corps central allongé (2) pourvu d'un canal de passage (3) pour des lignes de boroscope et d?un dispositif d?écartement (4) qui s?étend de façon variable en direction radiale sur toute la périphérie du corps central (2) et sert d?appui au corps central (2) dans au moins deux plans d'appui (5) espacés les uns des autres le long du corps central (2) et s'étendant respectivement perpendiculairement à la direction longitudinale du corps central (2). L'ensemble (10) comprenant un boroscope (11) doté d?une tête de boroscopie (12) à une extrémité d'une tige de boroscope (13) dans laquelle s'étendent des lignes de boroscope, et un dispositif d?aide au centrage (1) selon l'invention, le dispositif d?aide au centrage (1) étant disposé directement au voisinage de la tête de boroscope (12) et les lignes de boroscope cheminant par le canal de passage du dispositif d?aide au centrage (1).
Patent CA-3207884-A1 (CA)
Title: Methode de synthese d'un tamis moleculaire de type structure mww
Inventor: SARTIPI SINA
IPC: C01B39/48
Filed: 2022-03-02
Abstract: L'invention concerne une méthode de synthèse d'un tamis moléculaire de type structure MWW et des tamis moléculaires ainsi synthétisés. La méthode comprend la préparation d'un mélange de synthèse pour former un tamis moléculaire de type structure MWW, ledit mélange de synthèse comprenant de l'eau, une source de silicium, une source d'un élément trivalent X, un agent directeur R de structure, une source de cation de métal alcalino-terreux ou alcalin M, et une source de cation de poly(diallyldiméthyl ammonium) (PDDA).
Patent CA-3208307-A1 (CA)
Title: Systeme et procede de presentation de produits divers a l'aide d'un systeme de rail d'etiquettes
Inventor: KOPP GRAHAM MICHAEL
IPC: A47F3/00
Filed: 2022-01-14
Abstract: Systèmes et procédés pour encadrer de manière sécurisée une enceinte au moyen d'un matériau inerte facilement formé et intégré, fournissant ainsi un environnement non réactif pour fixer un ou plusieurs objets. L'enceinte peut comprendre un corps de rail d'étiquette conçu pour soutenir une plateforme, qui, à son tour, soutient un objet à afficher : un support de dossier de rail, le support de dossier de rail étant conçu pour coulisser de manière sûre dans le corps de rail d'étiquette et venir en prise avec ce dernier : un modificateur de rebord conçu pour être fixé au corps de rail d'étiquette et conçu en outre pour accepter de manière sécurisée une vitrine afin d'afficher l'objet ; le corps de rail d'étiquette, le modificateur de rebord et la forme de vitrine étant assemblés pour fournir l'enceinte pour afficher l'objet.
Patent CA-3209140-A1 (CA)
Title: Highly sensitive surveillance using detection of cell free dna
Inventor: MITCHELL AOY TOMITA
IPC: G16B20/00
Filed: 2013-04-19
Abstract: Provided herein are methods and computer-readable storage media related to cell-free DNA and uses thereof to determine risk of a condition in a subject. In one embodiment, the method comprises analyzing nucleic acids from cell-free DNA extracted from a biological sample obtained from the subject to identify a plurality of loci, the nucleic acids comprising first nucleic acids of the subject and second nucleic acids not native to the subject; determining an allele of each of the plurality of loci; selecting at least one informative locus from the plurality of loci based on the determining of the allele; calculating an estimated allele frequency of a first allele at the at least one informative locus using a statistical distribution;  determining an amount of cell-free DNA not native to the subject in the cell-free DNA based on the estimated allele frequency; and determining a risk in the subject.
Patent CA-3211692-A1 (CA)
Inventor: PATEL SAJAL MANUBHAI
IPC: A61K9/00
Filed: 2021-02-23
Abstract: Provided are formulations of an antibody that specifically binds of endothelial lipase. The provided formulations may be in liquid form or reconstituted from a lyophilized form. The formulations have viscosities suitable for injection and prevent reversible self-association of the antibody, precipitation and cloudiness.
Patent CA-3212569-A1 (CA)
Title: Composite oromucosal film compositions comprising epinephrine particles
Inventor: MASEK JOSEF
IPC: A61K45/06
Filed: 2022-03-17
Abstract: The invention provides an oromucosal film composition comprising: a therapeutically effective amount of epinephrine solid particles having a particle size in the range of from about 0.01 um to about 100 um; and a pharmaceutically acceptable polymer wherein the epinephrine solid particles are dispersed in and/or disposed on a polymeric layer. The film compositions can be used for the treatment of anaphylactic shock, cardiac arrest, asthma, bronchial asthma, bronchitis, emphysema, respiratory infections, and allergic reactions. The film compositions may further contain local anesthetics and used for providing local anesthesia, such as for the treatment or prevention of tooth pain.
Patent CA-3213882-A1 (CA)
Title: Communications systems and methods for nuclear reactor tooling
Inventor: SZCZEPAN ANDRZEJ PIOTR
Filed: 2018-06-22
Abstract: Systems and methods for transmitting communications to and from tooling for a nuclear reactor are provided. Some systems include first and second tools including first and second tool controllers positioned on a platform located adjacent a face of the nuclear reactor, and a tooling controller communicatively coupled to the first and second tool controllers, wherein the tooling controller is configured to receive a communication from the second tool controller, wherein the communication includes an identifier of an operating state of the second tool, generate a control signal for controlling the first tool based at least in part on the identifier of the operating state of the second tool, and transmit the control signal to the first tool controller. Some systems include a display, memory and a processor configured to render a reactor equipment representation comprising status indicators, receive status messages, and update status indicators based upon the status messages.
Patent CA-3214902-A1 (CA)
Title: Natural fining agent for beverages
Inventor: KADAM SHEKHAR UMAKANTRAO
IPC: C12H1/052
Filed: 2022-05-09
Abstract: A fining formulation/agent contains pectin, particularly, low-methoxy pectin, and yeast extract. A method of fining beverages, particularly beers and wines, including adding the fining formulation/agent to a beverage, particularly during a fermented beverage manufacturing process.
Patent CA-3216893-A1 (CA)
Inventor: CHRISTIE DANE ALPHANSO
IPC: A61J1/14
Filed: 2022-04-19
Abstract: A sealed pharmaceutical container (100) comprises a shoulder (130), a neck (128) extending from the shoulder, and a flange (126) extending from the neck. The flange comprises an outer surface (136) extending from the underside surface (132) and a contact surface (138) extending between the outer surface and an inner surface defining an opening (105) in the sealed pharmaceutical container. The contact surface comprises an outer peripheral edge (142) disposed proximate to the outer surface of the flange. The sealed pharmaceutical container comprises a sealing assembly (104) comprising a stopper (106) extending over the contact surface of the flange and covering the opening, and a cap (108) securing the stopper to the flange. The stopper comprises a sealing surface that is secured in contact with the contact surface of the flange to form a seal between the flange and the stopper. An outer peripheral edge of the sealing surface is disposed at or radially inward of the outer peripheral edge.
Patent CA-3217866-A1 (CA)
Inventor: LASSER ROBERT ALFONSO
IPC: A61K31/58
Filed: 2022-04-29
Abstract: La présente invention concerne un composé (1), ou un sel pharmaceutiquement acceptable correspondant, destiné à être utilisé dans des méthodes de traitement de la dépression post-partum (DPP) chez un patient féminin humain pendant la période postnatale du patient, le patient allaitant un enfant durant la période de traitement. L'invention concerne également un composé (1), ou un sel pharmaceutiquement acceptable correspondant, destiné à être utilisé dans des méthodes de traitement d'un trouble dépressif majeur (TDM) chez un patient féminin humain, le patient allaitant un enfant durant la période de traitement.
Patent CA-3218021-A1 (CA)
Title: Reconfigurable bioprocessing system
Inventor: LUNDIN ANDREAS
IPC: C12M1/00
Filed: 2022-04-25
Abstract: The present disclosure relates to a reconfigurable bioprocessing system (80) operable to perform a predetermined set of bioprocessing operations within the bioprocessing system (80), the bioprocessing system (80) comprising: a base unit (60) comprising a plurality of valve actuators, wherein at least one of the plurality of valve actuators is configured to releasably engage with a membrane valve cassette (200, 300, 400) that is removably attachable to the base unit (60), and wherein the at least one of the plurality of valve actuators is actuatable to regulate fluid flow through the membrane valve cassette (200, 300, 400); and a control system (20) operable to selectively actuate respective ones of the plurality of valve actuators to provide a valve configuration within the membrane valve cassette (200, 300, 400) to enable the base unit (60) and the membrane valve cassette (200, 300, 400) together to perform one of the predetermined set of bioprocessing operations.
Patent CA-3218573-A1 (CA)
Title: Compounds for degrading alpha-synuclein aggregates and uses thereof
Inventor: JANG MING-KUEI
IPC: A61K47/55
Filed: 2021-05-14
Abstract: The present disclosure provides compounds comprising an E3 ubiquitin ligase binding moiety and an alpha-synuclein protein binding moiety for use in the treatment of neurodegenerative diseases, in particular synucleinopathies.
Patent CA-3219413-A1 (CA)
Inventor: RONAGHI MOSTAFA
IPC: C12Q1/6869
Filed: 2015-05-14
Abstract: A method for synthesizing a nucleic acid includes synthesizing one or more nucleic acid fragments on a substrate. The synthesized one or more nucleic acid fragments may be amplified on the substrate. The method also includes sequencing the synthesized or amplified one or more nucleic acid fragments on the substrate. The sequencing may provide feedback to designs of the one or more nucleic acid fragments. The method further includes harvesting the synthesized or amplified one or more nucleic acid fragments based on sequencing. The synthesized or amplified one or more nucleic acid fragments may be assembled to generate a target nucleic acid.